Rankings
▼
Calendar
BIIB FY 2016 Earnings — Biogen Inc. Revenue & Financial Results | Market Cap Arena
BIIB
Biogen Inc.
$28B
FY 2016 Earnings
Healthcare
Drug Manufacturers - General
Income Statement
Revenue
$11.4B
+6.4% YoY
Gross Profit
$10.0B
87.5% margin
Operating Income
$5.2B
45.0% margin
Net Income
$3.7B
32.3% margin
EPS (Diluted)
$16.93
Cash Flow
Operating Cash Flow
$4.5B
Free Cash Flow
$3.9B
Stock-Based Comp.
$155M
Balance Sheet
Total Assets
$22.9B
Total Liabilities
$10.7B
Stockholders' Equity
$12.1B
Cash & Equivalents
$2.3B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$11.4B
$10.8B
+6.4%
Gross Profit
$10.0B
$9.5B
+5.2%
Operating Income
$5.2B
$4.9B
+5.3%
Net Income
$3.7B
$3.5B
+4.4%
← FY 2015
All Quarters
Q1 2016 →